FutureChem Co.,Ltd (220100.KQ)

KRW 18200.0

(0.94%)

Net Income Summary of FutureChem Co.,Ltd

  • FutureChem Co.,Ltd's latest annual net income in 2023 was -6.7 Billion KRW , up 51.94% from previous year.
  • FutureChem Co.,Ltd's latest quarterly net income in 2024 Q1 was -1.87 Billion KRW , down -9.89% from previous quarter.
  • FutureChem Co.,Ltd reported an annual net income of -13.95 Billion KRW in 2022, down -308.22% from previous year.
  • FutureChem Co.,Ltd reported an annual net income of -3.41 Billion KRW in 2021, up 85.2% from previous year.
  • FutureChem Co.,Ltd reported a quarterly net income of -3.45 Billion KRW for 2024 Q2, down -84.49% from previous quarter.
  • FutureChem Co.,Ltd reported a quarterly net income of -6.7 Billion KRW for 2023 FY, up 51.94% from previous quarter.

Annual Net Income Chart of FutureChem Co.,Ltd (2023 - 2016)

Historical Annual Net Income of FutureChem Co.,Ltd (2023 - 2016)

Year Net Income Net Income Growth
2023 -6.7 Billion KRW 51.94%
2022 -13.95 Billion KRW -308.22%
2021 -3.41 Billion KRW 85.2%
2020 -23.1 Billion KRW -330.35%
2019 -5.36 Billion KRW 55.15%
2018 -11.96 Billion KRW -166.52%
2017 -4.49 Billion KRW 83.54%
2016 -27.28 Billion KRW 0.0%

Peer Net Income Comparison of FutureChem Co.,Ltd

Name Net Income Net Income Difference
HLB Pharmaceutical Co., Ltd -19.42 Billion KRW 65.467%
CMG Pharmaceutical Co., Ltd. 6.45 Billion KRW 203.928%
Celltrion Pharm, Inc. 21.26 Billion KRW 131.549%
Huons Global Co., Ltd. 38.38 Billion KRW 117.479%
DongKook Pharmaceutical Co., Ltd. 47.17 Billion KRW 114.221%
Enzychem Lifesciences Corporation -9.32 Billion KRW 28.065%
Humedix Co., Ltd. 24.82 Billion KRW 127.03%
Boditech Med Inc. 25.94 Billion KRW 125.857%
EuBiologics Co., Ltd. -13.87 Billion KRW 51.661%
Huons Co., Ltd. 50.47 Billion KRW 113.292%
BNC Korea Co., Ltd. 25.68 Billion KRW 126.119%
AptaBio Therapeutics Inc. -12.06 Billion KRW 44.378%